BR0111916A - Métodos e composição para vacinação oral - Google Patents

Métodos e composição para vacinação oral

Info

Publication number
BR0111916A
BR0111916A BR0111916-8A BR0111916A BR0111916A BR 0111916 A BR0111916 A BR 0111916A BR 0111916 A BR0111916 A BR 0111916A BR 0111916 A BR0111916 A BR 0111916A
Authority
BR
Brazil
Prior art keywords
vaccine
animal
methods
mixing
formulation
Prior art date
Application number
BR0111916-8A
Other languages
English (en)
Inventor
Hsien-Jue Steve Chu
Wumin Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0111916A publication Critical patent/BR0111916A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODOS E COMPOSIçãO PARA VACINAçãO ORAL". A presente invenção abrange métodos e composições tanto para oferecer proteção contra doenças em um animal quanto para induzir ingestão aumentada de uma vacina administrável por via oral por um animal. Os métodos da invenção referem-se a misturar um antígeno bacteriano ou viral com um flavorizante saboroso solúvel em água, misturar ainda a mistura de flavorizante e antígeno com um veículo solúvel em água para administração oral da vacina a um animal para oferecer proteção contra doenças associadas com infecção pelo antígeno misturado e para induzir a ingestão aumentada da vacina com o flavorizante. A presente invenção abrange assim métodos e composições para vacinação oral de animais saudáveis através da água potável ou de xaropes como adjuvante na prevenção da doença. A misturação do flavorizante saboroso oferece uma formulação de vacina com um sabor desejável para promover auto-administração da formulação de vacina e/ou para impedir rejeição da formulação quando administrada por um tratador de animais.
BR0111916-8A 2000-06-30 2001-06-22 Métodos e composição para vacinação oral BR0111916A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21535900P 2000-06-30 2000-06-30
PCT/US2001/020155 WO2002002139A2 (en) 2000-06-30 2001-06-22 Methods and composition for oral vaccination

Publications (1)

Publication Number Publication Date
BR0111916A true BR0111916A (pt) 2003-05-13

Family

ID=22802674

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111916-8A BR0111916A (pt) 2000-06-30 2001-06-22 Métodos e composição para vacinação oral

Country Status (18)

Country Link
US (2) US20020025325A1 (pt)
EP (1) EP1294399A2 (pt)
JP (1) JP2004501979A (pt)
KR (1) KR20030013480A (pt)
CN (1) CN100457179C (pt)
AR (1) AR030702A1 (pt)
AU (2) AU7013501A (pt)
BG (1) BG107282A (pt)
BR (1) BR0111916A (pt)
CZ (1) CZ20024222A3 (pt)
HU (1) HUP0301394A3 (pt)
MX (1) MXPA02012201A (pt)
MY (1) MY128159A (pt)
NZ (1) NZ523329A (pt)
PL (1) PL360026A1 (pt)
WO (1) WO2002002139A2 (pt)
YU (1) YU99102A (pt)
ZA (1) ZA200210402B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008032796A1 (fr) 2006-09-13 2008-03-20 Nippon Zenyaku Kogyo Co., Ltd. Nouveau vaccin canin
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2008070332A2 (en) * 2006-10-25 2008-06-12 Intervet International B.V. Feline influenza vaccine and method of use
LT2762163T (lt) * 2006-12-27 2018-02-26 Zoetis Services Llc Vakcinos įvedimo būdai
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
JP5257939B2 (ja) * 2009-02-24 2013-08-07 独立行政法人農業・食品産業技術総合研究機構 豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン
BR112012000951A2 (pt) * 2009-07-17 2016-03-15 Univ Oklahoma State método para imunizar um animal, formulação imunogênica, e, aplicador supralingual
US8453601B2 (en) * 2011-05-19 2013-06-04 C-Lock Inc. Vaccine and health-related applications for ruminant breath monitoring system
MX2015005491A (es) * 2012-11-05 2015-07-23 Nestec Sa Aguas potables saborizadas y metodos para mejorar la hidratacion para animales.
US9655962B2 (en) 2013-03-15 2017-05-23 Camas Incorporated Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
RU2749423C2 (ru) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Способ получения стерилизованного влажного кормового продукта для домашних животных
BR112019010394A2 (pt) * 2016-11-29 2019-09-03 Intervet Int Bv vacina suína
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
AU2017376919A1 (en) 2016-12-15 2018-12-13 Société des Produits Nestlé S.A. Compositions and methods that modulate bacteria in a companion animal
EP3906049A1 (en) * 2019-01-04 2021-11-10 Boehringer Ingelheim Animal Health USA Inc. Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof
KR102234525B1 (ko) * 2020-08-28 2021-03-30 안병철 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN115040468B (zh) * 2022-05-16 2023-02-07 中国农业科学院北京畜牧兽医研究所 一种中大体型动物口服免疫或给药“辣条”及其生产方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine
US3224941A (en) * 1963-01-21 1965-12-21 Lilly Co Eli Resin compositions and method for controlling diarrhea
GB1102676A (en) * 1965-10-08 1968-02-07 Hart Mfg Co H W Apparatus for supplying water to fowls
DE1792256C3 (de) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US4141229A (en) * 1977-10-11 1979-02-27 Stanly Knitting Mills, Inc. Knit cap with elastic head band
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
EP0651609B1 (en) * 1990-06-13 1999-08-11 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5846805A (en) * 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5419907A (en) * 1992-11-10 1995-05-30 Iowa State University Research Foundation, Inc. Pathogenic porcine respiratory coronavirus
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
FR2710500B1 (fr) * 1993-09-27 1995-12-01 Virbac Laboratoires Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications.
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
US5985336A (en) * 1995-06-07 1999-11-16 Novus International, Inc. Nutrient formulation and process for feeding young poultry and other animals
US5884583A (en) * 1997-03-28 1999-03-23 Rhone Merieux, Inc. Field bag boost vaccination delivery system
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US20020064517A1 (en) * 1998-04-30 2002-05-30 Stewart A. Cederholm-Williams Fibrin sealant as a transfection/transformation vehicle for gene therapy
EP1076567A4 (en) * 1998-05-15 2001-12-12 Mkb Invest Ltd Partnership COMPOSITION AND METHOD FOR IMMUNIZATION OF POULTRY
US6399074B1 (en) * 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine

Also Published As

Publication number Publication date
AU2001270135B2 (en) 2005-05-26
ZA200210402B (en) 2004-03-23
PL360026A1 (en) 2004-09-06
AU7013501A (en) 2002-01-14
JP2004501979A (ja) 2004-01-22
CZ20024222A3 (cs) 2003-06-18
BG107282A (bg) 2003-06-30
WO2002002139A3 (en) 2002-07-04
HUP0301394A3 (en) 2004-10-28
EP1294399A2 (en) 2003-03-26
CN1529615A (zh) 2004-09-15
AR030702A1 (es) 2003-09-03
NZ523329A (en) 2005-10-28
HUP0301394A2 (hu) 2003-08-28
KR20030013480A (ko) 2003-02-14
WO2002002139A2 (en) 2002-01-10
US20020025325A1 (en) 2002-02-28
US20060171960A1 (en) 2006-08-03
MXPA02012201A (es) 2003-06-06
MY128159A (en) 2007-01-31
CN100457179C (zh) 2009-02-04
YU99102A (sh) 2006-01-16

Similar Documents

Publication Publication Date Title
BR0111916A (pt) Métodos e composição para vacinação oral
US20090311197A1 (en) Method and Compositions for Oral Hygiene
JPS6212A (ja) メチルスルホニルメタンを含む食餌製品およびその使用
HUE035426T2 (hu) Probiotikus és prebiotikus komponenseket és ásványi sókat tartalmazó készítmények laktoferrinnel
BR0211049A (pt) Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
KR20200024185A (ko) A형 인플루엔자 바이러스의 치료 또는 경감을 위한 항바이러스제
MacLeod The treatment of cattle by homoeopathy
TW200803865A (en) Composition containing riboflavin and sesamins
ES2758674T3 (es) Uso de taurina en la prevención y/o tratamiento de enfermedades inducidas por los virus del género coronavirus y/o del género rotavirus
CN103908423B (zh) 抗口腔幽门螺杆菌中药牙膏
CN101721604B (zh) 一种中药组合物在制备治疗手口足病药物中的应用
CN101721515B (zh) 一种中药组合物在制备治疗手口足病药物中的应用
JP2000273051A (ja) 苦みがマスキングされた液状製剤
MacLeod Pigs: The Homoeopathic Approach to the Treatment and Prevention of Diseases
ES2304246T3 (es) Compuestos cosmeticos y farmaceuticos con contenido de licopina.
Mishra et al. Herbal treatment for common diseases in ruminants: an overview.
MacLeod Dogs: homoeopathic remedies
BRPI0419125A (pt) composição farmacêutica e processo para a preparação de uma composição farmacêutica
Taylor IV et al. PALA in advanced breast cancer A phase II pilot study by the ECOG
AU2017101788A4 (en) Nutritional supplements and methods of use
US20030199430A1 (en) Zinc formulations as a prophylactic treatment for the common cold
ES2685329B1 (es) Composición bucal para la limpieza profunda de boca
Smith Studies on Nutrition in Experimental Tuberculosis: I. The Effect of the Fat-Soluble A Vitamine on Tuberculosis of the Guinea Pig, with Especial Reference to the Value of Codliver Oil in Experimental Tuberculosis
ES2575736T3 (es) Composición de extractos ricos en elagitaninos para el bienestar sexual
CN108812534A (zh) 一种防牛副伤寒病的养牛方法

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.